ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep
March 13, 2023 07:00 ET
|
ResMed Inc.
81% of respondents experience one or more symptoms indicating poor sleep quality, despite 64% saying they’re satisfied with the quantity of their sleepWomen and older generations are less satisfied...
ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023 09:00 ET
|
ResMed Inc.
SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 33rd Annual Healthcare...
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023
January 26, 2023 16:05 ET
|
ResMed Inc.
Year-over-year revenue grows 16%, operating profit up 13%, non-GAAP operating profit up 14% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today...
ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
January 26, 2023 16:05 ET
|
ResMed Inc.
SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced ResMed’s board of directors has appointed chief executive officer Michael (“Mick”) Farrell as chair of the...
ResMed to Report Second Quarter Fiscal 2023 Earnings on January 26, 2023
January 12, 2023 09:00 ET
|
ResMed Inc.
SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2023 on...
ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference
January 02, 2023 16:05 ET
|
ResMed Inc.
SAN DIEGO, Jan. 02, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on...
ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
November 22, 2022 09:00 ET
|
ResMed Inc.
- Acquisition expands ResMed’s SaaS business to Germany, first non-U.S. market - Outpatient therapy services added to ResMed’s growing SaaS offering portfolio - Purchase price of €958.6 million...
ResMed Opens Manufacturing Centre in Singapore, Expanding Manufacturing Footprint to Support Growth, Development, and Production of Digital Health Solutions
November 16, 2022 18:30 ET
|
ResMed Inc.
New 270,000-square-foot (25,000-square-meter) facility in Tuas marks the next stage in ResMed’s more than decade-long presence in Singapore; will account for nearly 1,000 jobs across a variety of...
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023
October 27, 2022 16:05 ET
|
ResMed Inc.
Year-over-year revenue grows 5%, operating profit up 5%, non-GAAP operating profit up 4% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today...
ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022
October 13, 2022 16:05 ET
|
ResMed Inc.
SAN DIEGO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2023 on Thursday,...